A Wall Street quant chief breaks down why a COVID-19 vaccine is not the silver bullet investors have been hoping for — and warns another stock-market meltdown is likely
Two things broadly explain the speed of the snapback: the government's swift delivery of stimulus to Americans of all income levels, and the steady progress that pharmaceutical companies are making towards unleashing an effectiveThat second catalyst is why investors are anticipating a permanent solution to the worst global health crisis since the 1918 Spanish flu.
When it comes to the vaccine, Lapthorne has four specific concerns that throw cold water on the silver-bullet narrative. under development, there is no guarantee that any will be effective on a massive scale. He also says that HIV still does not have a vaccine, although it's worth noting that there are treatments to keep people living with it healthy.
Fourth, it will take some time for people to unlearn their new pandemic habits and return to pre-COVID behavior even after a vaccine is available. Those habits include traveling by public transport, attending social events, and in-person gatherings — all of which help drive company revenues and overall economic activity.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
'Underserved and underfunded': Inside California's county hit hardest by COVID-19As most of California begins a second shutdown over the coronavirus outbreak, no place has been hit as hard as Imperial County.
Read more »
Fauci optimistic COVID-19 vaccine will be widely availableOnce a coronavirus vaccine is approved as safe and effective, Americans should have widespread access within a reasonable time, Dr. Anthony Fauci assured lawmakers Friday. Appearing before a House panel investigating the nation&39;s response to the pandemic, Fauci expressed “cautious” optimism that
Read more »
U.S. To Spend $2.1 Billion On GlaxoSmithKline-Sanofi Covid-19 VaccineThe U.S. agreed to spend $2.1 billion on a joint experimental Covid-19 vaccine from GlaxoSmithKline and Sanofi to supply the nation with an initial 100 million doses by iamsternlicht
Read more »
Vaccine companies searching for 1-shot dose of COVID-19 vaccineVaccine companies searching for 1-shot dose of COVID-19 vaccine.
Read more »
Fauci optimistic Covid-19 vaccine will be widely availableUnder direction from the White House, federal health authorities are carrying out a plan dubbed Operation Warp Speed to manufacture 300 million doses of a vaccine on a compressed timeline.
Read more »
U.S. Drops $2.1 Billion on Experimental COVID-19 VaccineThe U.S. will pay “for development including clinical trials, manufacturing, scale-up and delivery of its vaccine'
Read more »